Marine microalgae are primary producers of DHA and EPA. They are a potentially valuable and sustainable source of omega-3 fatty acids due to their ability to grow rapidly on a non aerable land. Microalgae are known to produce about several times more oil than terrestrial oleaginous plants4. Additional advantages of microalgae oil are, lack of fishy taste or risk of fish allergy, their ability to withstand a variety of culture conditions thereby reducing carbon dioxide emission. Microalgae oil is also free from contaminants and cholesterol that are found in fish oils. Thus, microalgae oils can be produced on a large scale without significant environmental impact and therefore, are a sustainable alternative source to fish oil. However, production of quality algae oil on a larger scale can be challenging. From selection of appropriate algal strains (non-toxic, non-pathogenic), generating optimum culture conditions, high biomass production, to achieving optimum omega-3 acids proportions, it is important to maintain a fine balance of processing conditions2.
VivoMega Algae 0070 TGP and 0040TGP from GC Rieber is a high-quality ocean derived, vegan Omega-3 from microalgae, species Schizochytrium spp. Produced by GC Rieber’s proprietary SuperLight process. This process is designed specifically for algae oils that leverages proprietary refining, concentration, distillation and deodorization technologies and processes, and ensures a production process which is highly controlled with minimum exposure to heat and superior oxidation protection. High in DHA, VivoMega algae concentrate is >90% triglycerides which is the natural fat found in fish and mammals and has superior absorption in the human body.
Currently working at Quadra as Head of Formulation and Innovation. This is an industry liaison role through which Nilesh provides the required scientific, technical expertise and support to Quadra’s customers and suppliers. Before joining Quadra, Nilesh obtained a PhD in Pharmaceutical Sciences from University of British Columbia, Canada and have worked in the Pharmaceutical R&D and product development for over twelve years. Nilesh’s expertise includes end-to-end product development, scale-up and technology transfer for a variety of dosage forms. Nilesh possesses extensive knowledge of ingredients and their functionality in the finished products. Nilesh has six research articles published in high impact international journals with over one hundred citations.